{"id":38865,"date":"2025-08-08T14:38:01","date_gmt":"2025-08-08T06:38:01","guid":{"rendered":"https:\/\/flcube.com\/?p=38865"},"modified":"2025-08-08T14:38:02","modified_gmt":"2025-08-08T06:38:02","slug":"westgene-partners-with-bgi-huo-yan-for-mrna-drug-development-and-industrialization","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=38865","title":{"rendered":"Westgene Partners with BGI Huo-Yan for mRNA Drug Development and Industrialization"},"content":{"rendered":"\n

Chengdu Westgene Biopharma announced the establishment of a strategic partnership with Shenzhen BGI Huo-Yan Engineering Technology Co., Ltd., a subsidiary of BGI Group. The collaboration focuses on the development and industrialization of mRNA drugs, leveraging Westgene’s proprietary ionizable lipid technology.<\/p>\n\n\n\n

Partnership Details<\/strong>
Westgene’s self-developed ionizable lipid has been licensed to BGI Huo-Yan as the core lipid for lipid nanoparticles (LNPs). This collaboration will support the global research, development, production, and commercialization of BGI Huo-Yan’s vaccine projects. Under the agreement, Westgene will receive direct payments totaling up to RMB 1.1 billion, including upfront payments, preclinical and clinical development milestones, and commercialization milestones. Additionally, if the products are successfully launched, Westgene will share in the proceeds. Westgene will also become a strategic supplier to BGI Huo-Yan Engineering.<\/p>\n\n\n\n

Global Intellectual Property and Technical Advantages<\/strong>
Westgene’s ionizable lipid has established a comprehensive global intellectual property landscape, covering major markets such as China, the United States, Europe, and Japan. The LNP prepared using this novel chemical structure lipid has entered clinical trials. Interim data demonstrate superior safety, targeting (extrahepatic), mRNA translation protein levels, and storage stability (stable storage for over 18 months at room temperature) compared to existing commercially available excipients.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Chengdu Westgene Biopharma announced the establishment of a strategic partnership with Shenzhen BGI Huo-Yan Engineering…<\/p>\n","protected":false},"author":1,"featured_media":38866,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[63,12,402],"class_list":["post-38865","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-mrna","tag-vaccine","tag-westgene-biopharma"],"yoast_head":"\nWestgene Partners with BGI Huo-Yan for mRNA Drug Development and Industrialization - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Chengdu Westgene Biomedical Technology Co., Ltd. ("Westgene") announced the establishment of a strategic partnership with Shenzhen BGI Huo-Yan Engineering Technology Co., Ltd., a subsidiary of BGI Group. The collaboration focuses on the development and industrialization of mRNA drugs, leveraging Westgene's proprietary ionizable lipid technology.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=38865\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Westgene Partners with BGI Huo-Yan for mRNA Drug Development and Industrialization\" \/>\n<meta property=\"og:description\" content=\"Chengdu Westgene Biomedical Technology Co., Ltd. ("Westgene") announced the establishment of a strategic partnership with Shenzhen BGI Huo-Yan Engineering Technology Co., Ltd., a subsidiary of BGI Group. The collaboration focuses on the development and industrialization of mRNA drugs, leveraging Westgene's proprietary ionizable lipid technology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=38865\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-08T06:38:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-08T06:38:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/0806.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38865#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38865\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Westgene Partners with BGI Huo-Yan for mRNA Drug Development and Industrialization\",\"datePublished\":\"2025-08-08T06:38:01+00:00\",\"dateModified\":\"2025-08-08T06:38:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38865\"},\"wordCount\":213,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38865#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/0806.webp\",\"keywords\":[\"mRNA\",\"Vaccine\",\"WestGene Biopharma\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=38865#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38865\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=38865\",\"name\":\"Westgene Partners with BGI Huo-Yan for mRNA Drug Development and Industrialization - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38865#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38865#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/0806.webp\",\"datePublished\":\"2025-08-08T06:38:01+00:00\",\"dateModified\":\"2025-08-08T06:38:02+00:00\",\"description\":\"Chengdu Westgene Biomedical Technology Co., Ltd. (\\\"Westgene\\\") announced the establishment of a strategic partnership with Shenzhen BGI Huo-Yan Engineering Technology Co., Ltd., a subsidiary of BGI Group. The collaboration focuses on the development and industrialization of mRNA drugs, leveraging Westgene's proprietary ionizable lipid technology.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38865#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=38865\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38865#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/0806.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/0806.webp\",\"width\":1080,\"height\":608,\"caption\":\"Westgene Partners with BGI Huo-Yan for mRNA Drug Development and Industrialization\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38865#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Westgene Partners with BGI Huo-Yan for mRNA Drug Development and Industrialization\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Westgene Partners with BGI Huo-Yan for mRNA Drug Development and Industrialization - Insight, China's Pharmaceutical Industry","description":"Chengdu Westgene Biomedical Technology Co., Ltd. (\"Westgene\") announced the establishment of a strategic partnership with Shenzhen BGI Huo-Yan Engineering Technology Co., Ltd., a subsidiary of BGI Group. The collaboration focuses on the development and industrialization of mRNA drugs, leveraging Westgene's proprietary ionizable lipid technology.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=38865","og_locale":"en_US","og_type":"article","og_title":"Westgene Partners with BGI Huo-Yan for mRNA Drug Development and Industrialization","og_description":"Chengdu Westgene Biomedical Technology Co., Ltd. (\"Westgene\") announced the establishment of a strategic partnership with Shenzhen BGI Huo-Yan Engineering Technology Co., Ltd., a subsidiary of BGI Group. The collaboration focuses on the development and industrialization of mRNA drugs, leveraging Westgene's proprietary ionizable lipid technology.","og_url":"https:\/\/flcube.com\/?p=38865","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-08-08T06:38:01+00:00","article_modified_time":"2025-08-08T06:38:02+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/0806.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=38865#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=38865"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Westgene Partners with BGI Huo-Yan for mRNA Drug Development and Industrialization","datePublished":"2025-08-08T06:38:01+00:00","dateModified":"2025-08-08T06:38:02+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=38865"},"wordCount":213,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=38865#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/0806.webp","keywords":["mRNA","Vaccine","WestGene Biopharma"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=38865#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=38865","url":"https:\/\/flcube.com\/?p=38865","name":"Westgene Partners with BGI Huo-Yan for mRNA Drug Development and Industrialization - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=38865#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=38865#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/0806.webp","datePublished":"2025-08-08T06:38:01+00:00","dateModified":"2025-08-08T06:38:02+00:00","description":"Chengdu Westgene Biomedical Technology Co., Ltd. (\"Westgene\") announced the establishment of a strategic partnership with Shenzhen BGI Huo-Yan Engineering Technology Co., Ltd., a subsidiary of BGI Group. The collaboration focuses on the development and industrialization of mRNA drugs, leveraging Westgene's proprietary ionizable lipid technology.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=38865#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=38865"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=38865#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/0806.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/0806.webp","width":1080,"height":608,"caption":"Westgene Partners with BGI Huo-Yan for mRNA Drug Development and Industrialization"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=38865#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Westgene Partners with BGI Huo-Yan for mRNA Drug Development and Industrialization"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/0806.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/38865","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=38865"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/38865\/revisions"}],"predecessor-version":[{"id":38867,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/38865\/revisions\/38867"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/38866"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=38865"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=38865"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=38865"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}